Hims & Hers Health shares fell 18% on Tuesday after the telehealth company posted a third-quarter loss and lowered its full-year profit outlook. The stock traded at $18.89 at about 2:50 p.m. Eastern time, down $4.05 from Monday’s close of $22.94, and fell as low as $18.40 earlier. The shares had already fallen 11.8% on Monday before the results came out after the close.
Revenue rose 49% to $890.4 million in the third quarter, the company said Monday. But it posted a net loss of $33.0 million, or 14 cents a share, compared with net income of $15.8 million a year earlier. Gross margin fell to 57% from 74%.
The company cut its 2026 adjusted EBITDA forecast to $257 million to $277 million, from $275 million to $325 million, and narrowed its full-year revenue outlook to $3.13 billion to $3.15 billion, from $3.1 billion to $3.3 billion. For the fourth quarter, it expects revenue of $875 million to $895 million.
Subscribers grew 13% from a year earlier to nearly 2.8 million.
